These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189 [No Abstract] [Full Text] [Related]
8. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301 [TBL] [Abstract][Full Text] [Related]
10. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives. Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V Front Physiol; 2019; 10():1476. PubMed ID: 31920689 [TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361 [TBL] [Abstract][Full Text] [Related]
13. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Yang J; Xu R; Wang C; Qiu J; Ren B; You L Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845 [TBL] [Abstract][Full Text] [Related]
14. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors. Pinzani P; D'Argenio V; Del Re M; Pellegrini C; Cucchiara F; Salvianti F; Galbiati S Clin Chem Lab Med; 2021 Jun; 59(7):1181-1200. PubMed ID: 33544478 [TBL] [Abstract][Full Text] [Related]
15. The potential of liquid biopsy in the management of cancer patients. Markou A; Tzanikou E; Lianidou E Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850 [TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer. Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817 [TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors. Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Theocharis SE Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768955 [TBL] [Abstract][Full Text] [Related]
18. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy. Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM Cells; 2019 Dec; 8(12):. PubMed ID: 31861130 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618 [TBL] [Abstract][Full Text] [Related]
20. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]